Guided by Evolution: Biology-Oriented Synthesis of Bioactive Compound Classes
暂无分享,去创建一个
[1] Kamal Kumar,et al. Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery. , 2016, Angewandte Chemie.
[2] Gianni Chessari,et al. From fragment to clinical candidate--a historical perspective. , 2009, Drug discovery today.
[3] R. Hicklin,et al. Synthesis of complex and diverse compounds through ring distortion of abietic acid. , 2014, Angewandte Chemie.
[4] D. O'Hagan. Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids (1998 to 1999) , 2000 .
[5] H. Waldmann,et al. An enantioselective inverse-electron-demand imino Diels-Alder reaction. , 2014, Angewandte Chemie.
[6] Roderick E Hubbard,et al. How well can fragments explore accessed chemical space? A case study from heat shock protein 90. , 2011, Journal of medicinal chemistry.
[7] Markus Schürmann,et al. Branching cascades: a concise synthetic strategy targeting diverse and complex molecular frameworks. , 2011, Angewandte Chemie.
[8] Michael H Hecht,et al. Cofactor binding and enzymatic activity in an unevolved superfamily of de novo designed 4‐helix bundle proteins , 2009, Protein science : a publication of the Protein Society.
[9] Michal Vieth,et al. Drugs in other drugs: a new look at drugs as fragments. , 2007, Drug discovery today.
[10] J. Briscoe,et al. The mechanisms of Hedgehog signalling and its roles in development and disease , 2013, Nature Reviews Molecular Cell Biology.
[11] Herbert Waldmann,et al. Discovery of Novel Cinchona-Alkaloid-Inspired Oxazatwistane Autophagy Inhibitors. , 2017, Angewandte Chemie.
[12] C. Schmidt,et al. Neuronal growth promoting sesquiterpene-neolignans; syntheses and biological studies. , 2012, Organic & biomolecular chemistry.
[13] B. Stockwell,et al. Neurobiological applications of small molecule screening. , 2008, Chemical reviews.
[14] T. Prisinzano. Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse. , 2009, Journal of natural products.
[15] R. Moon,et al. WNT signalling pathways as therapeutic targets in cancer , 2012, Nature Reviews Cancer.
[16] D. O'Hagan. Pyrrole, pyrrolidine pyridine, piperidine, azepine and tropane alkaloids , 1997 .
[17] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[18] A. Fürstner. Gold and platinum catalysis--a convenient tool for generating molecular complexity. , 2009, Chemical Society reviews.
[19] C. Dobson. Chemical space and biology , 2004, Nature.
[20] H. Schöler,et al. Discovery of neuritogenic compound classes inspired by natural products. , 2013, Angewandte Chemie.
[21] J. L. Howard,et al. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers. , 2004, Journal of medicinal chemistry.
[22] Herbert Waldmann,et al. Target identification for small bioactive molecules: finding the needle in the haystack. , 2013, Angewandte Chemie.
[23] R. Kehlenbach,et al. CRM1-mediated nuclear export: to the pore and beyond. , 2007, Trends in cell biology.
[24] K. Gademann,et al. A unified approach for the stereoselective total synthesis of pyridone alkaloids and their neuritogenic activity. , 2011, Angewandte Chemie.
[25] Gerhard Klebe,et al. A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes. , 2011, Journal of medicinal chemistry.
[26] S. Chandrasekhar,et al. Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity. , 2012, Bioorganic & medicinal chemistry letters.
[27] H. Schöler,et al. Highly enantioselective catalytic synthesis of neurite growth-promoting secoyohimbanes. , 2013, Chemistry & biology.
[28] K. Choi. Autophagy and cancer , 2012, Experimental & Molecular Medicine.
[29] G. Grynkiewicz,et al. Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. , 2008, Pharmacological reports : PR.
[30] H. Waldmann,et al. Enantiodivergent Combination of Natural Product Scaffolds Enabled by Catalytic Enantioselective Cycloaddition. , 2016, Angewandte Chemie.
[31] Su Qiu,et al. Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. , 2006, Journal of medicinal chemistry.
[32] M. Butler. Natural products to drugs: natural product-derived compounds in clinical trials. , 2005, Natural product reports.
[33] X. Wang,et al. Nucleophosmin and human cancer. , 2006, Cancer detection and prevention.
[34] S. Singh,et al. Chemistry, design, and structure-activity relationship of cocaine antagonists. , 2000, Chemical reviews.
[35] K. Scheidt,et al. Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents. , 2007, Angewandte Chemie.
[36] Stuart L Schreiber,et al. Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.
[37] Nature of the intermediates in gold(I)-catalyzed cyclizations of 1,5-enynes. , 2011, Chemistry.
[38] D. Newman,et al. Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.
[39] L. Hsieh‐Wilson,et al. Neuroactive chondroitin sulfate glycomimetics. , 2008, Journal of the American Chemical Society.
[40] Gisbert Schneider,et al. Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.
[41] S. Laphookhieo,et al. Alstoniaphyllines A-C, unusual nitrogenous derivatives from the bark of Alstonia macrophylla. , 2013, Journal of natural products.
[42] D. Enders,et al. Asymmetric organocatalytic domino reactions. , 2007, Angewandte Chemie.